Although Danish registry studies have reported transient benefits from GLP-1 agonist use on alcohol-related outcomes, comprehensive data on long-term impacts and broader clinical effectiveness are limited
Monitor and record: Keep a simple hydration diary, particularly during the first few weeks of treatment or after dose increases
Their half-lives are 13 hours (LIRA) and 7 days (SEMA), allowing for daily and weekly subcutaneous administration, respectively, thanks to the structural modifications introduced.5,10 Effects on obesity and glycaemic control Both LIRA 3 mg and SEMA 2.4 mg have demonstrated a strong appetite-suppressing and satiety-promoting effect, as well as a delaying effect on gastric emptying.11,12 The SCALE programme highlighted the efficacy of LIRA 3 mg in reducing body weight and waist circumference13 and confirmed a reduction in HbA1c levels in individuals with diabetes, along with a decreased progression from prediabetes to diabetes after three years of treatment14 (Table 1)
These results are summarized in Table 2
Over time, our business was expanded to other countries or markets like USA, Canada, Europe and Middle East
